This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Lamotrigine - 25 mg

Starting date:
May 27, 2013
Posting date:
June 6, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety, Quality
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-33953

Recalled products

  1. Lamotrigine - 25 mg

Reason

Quality concerns at the manufacturing facility of the active ingredients used in the products.

Depth of distribution

Distributed to wholesalers / pharmacies across Canada

Affected products

A. Lamotrigine - 25 mg

DIN, NPN, DIN-HIM
DIN 02343010
Dosage form
  • Tablets
Strength
  • 25 mg
Lot or serial number
  • 36005R
  • 1039583
  • 1041529
  • 1055102
  • 1071322
  • 1090444
  • 1101442
  • 3003518
Companies
Recalling Firm
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA
Marketing Authorization Holder
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA

Date modified: